These xenografts studies evidenced that Res@AuNPs inhibit tumor growth, promote apoptosis, and decrease the expression of VEGF in tumor tissue without substantially affecting (as determined by hematoxylin and eosin staining) vital organs such as the liver, heart, spleen, and kidney. This evidence concerns the gene VEGFA and neoplasm.